Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 23,830 | reported | 01 Jun 2018 | tx 15+209,031−2,935 |
| Galecto, Inc. | 720 | reported | 18 Jun 2025 | tx 7+99,720 |
| Aimmune Therapeutics, Inc. | 0 | reported | 13 Oct 2020 | tx 19+897,615−900,253 |
| ARENA PHARMACEUTICALS INC | 0 | reported | 11 Mar 2022 | tx 26+300,095−60,096 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 18 Jun 2025 | GRANT_AWARD | Galecto, Inc. | 720 | 0.00 USD | deriv |
| 20 Jun 2024 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 17 Jun 2023 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 14 Jun 2022 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 3,067 | — | |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 4,085 | — | |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 4,167 | — | deriv |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 5,000 | — | deriv |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 5,000 | — | deriv |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 7,500 | — | deriv |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 7,202 | — | deriv |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 15,000 | — | deriv |
| 11 Mar 2022 | OTHER | ARENA PHARMACEUTICALS INC | 5,000 | — | deriv |
| 15 Jun 2021 | SALE | ARENA PHARMACEUTICALS INC | 1,223 | 66.36 USD | |
| 11 Jun 2021 | GRANT_AWARD | ARENA PHARMACEUTICALS INC | 3,067 | 0.00 USD | |
| 11 Jun 2021 | GRANT_AWARD | ARENA PHARMACEUTICALS INC | 7,202 | 0.00 USD | deriv |
| 26 May 2021 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 19 Jan 2021 | SALE | ARENA PHARMACEUTICALS INC | 1,327 | 80.50 USD | |
| 11 Dec 2020 | PURCHASE | ARENA PHARMACEUTICALS INC | 5 | 69.31 USD | |
| 08 Dec 2020 | PURCHASE | ARENA PHARMACEUTICALS INC | 5 | 66.25 USD | |
| 19 Nov 2020 | GRANT_AWARD | Galecto, Inc. | 18,000 | 0.00 USD | deriv |
| 19 Nov 2020 | GRANT_AWARD | Galecto, Inc. | 9,000 | 0.00 USD | deriv |
| 13 Oct 2020 | OTHER | Aimmune Therapeutics, Inc. | 89,250 | 34.50 USD | |
| 10 Oct 2020 | TENDER | Aimmune Therapeutics, Inc. | 30,422 | 34.50 USD | |
| 13 Oct 2020 | OTHER | Aimmune Therapeutics, Inc. | 350,000 | 3.82 USD | deriv |
1 purchase reported after at least 12 months of silence — most recent on 10 Mar 2020.